Last updated on November 2019

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of SHP647 in inducing clinical remission and endoscopic response in participants with moderate to severe Crohn's Disease.

Clinical Study Identifier: NCT03559517

Find a site near you

Start Over

The Alfred Hospital

Melbourne, Australia
  Connect »

Northside Gastroenterology

Cypress, TX United States
  Connect »

Gastro One

Germantown, TN United States
  Connect »

Clinical Trials of SWLA LLC

Lake Charles, LA United States
  Connect »

Om Research LLC

Lancaster, CA United States
  Connect »

Mater Hospital Brisbane

South Brisbane, Australia
  Connect »

Liverpool Hospital

Liverpool, Australia
  Connect »

Peak Gastroenterology Associates

Colorado Springs, CO United States
  Connect »

East Coast Institute for Research, LLC

Saint Augustine, FL United States
  Connect »

Atria Clinical Research

Little Rock, AR United States
  Connect »

Asthma and Allergy Associates PC - CRN

Colorado Springs, CO United States
  Connect »

Louisiana Research Center LLC

Shreveport, LA United States
  Connect »

Piedmont Healthcare

Statesville, NC United States
  Connect »

Digestive Disease Associates

Wyomissing, PA United States
  Connect »

Sana Klinikum Biberach

Biberach an der Riss, Germany
  Connect »

ETZ-Elisabeth

Tilburg, Netherlands
  Connect »

Lexmedica

Wroclaw, Poland
  Connect »

NWZ, location Alkmaar

Den Helder, Netherlands
  Connect »

Dr. J Breedt

Pretoria, South Africa
  Connect »

HP Clinical Research

Bountiful, UT United States
  Connect »

Medical University Reaviz

Samara, Russian Federation
  Connect »

Dr JP Wright

Claremont, South Africa
  Connect »

SHI Regional Clinical Hospital

Saratov, Russian Federation
  Connect »

Emmed Research

Pretoria, South Africa
  Connect »

New Cross Hospital

Wolverhampton, United Kingdom
  Connect »